Literature DB >> 2858374

Acetaminophen decreases adenosine 3'-phosphate 5'-phosphosulfate and uridine diphosphoglucuronic acid in rat liver.

J J Hjelle, G A Hazelton, C D Klaassen.   

Abstract

The purpose of this investigation was to determine the effects of acute administration of acetaminophen on adenosine 3'-phosphate 5'-phosphosulfate (PAPS) and UDP-glucuronic acid concentrations in fed male rats. Acetaminophen produced a dosage-dependent decline in rat hepatic PAPS concentrations which was significant after dosages of 150, 300, or 600 mg/kg, ip. The time course of the decline in PAPS values after 600 mg acetaminophen/kg showed that PAPS concentrations reached a nadir 1 hr after dosing (40% of control values). Serum sulfate concentrations were also decreased by large dosages of acetaminophen (32 and 15% of control 2 hr after 150 and 600 mg/kg, respectively) and a significant, positive correlation between serum sulfate and hepatic PAPS concentrations was noted. In addition, hepatic cysteine and glutathione concentrations were lowered by high dosages of acetaminophen. Hepatic UDP-glucuronic acid concentrations were greatly decreased for 2 hr after a dosage of 600 mg acetaminophen/kg (15, 23, and 42% of control 0.5, 1.0, and 2.0 hr after dosing, respectively) whereas 150 mg/kg produced a less pronounced and more transient decrease. These findings demonstrate that both PAPS and UDP-glucuronic acid concentrations in liver are decreased after administration of acetaminophen and imply that capacity-limited sulfation and glucuronidation of acetaminophen are due to a decrease in co-substrate availability.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2858374

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  10 in total

1.  Decrease of inorganic blood sulfate following treatment with selected antirheumatic drugs: potential consequence for articular cartilage.

Authors:  B J de Vries; P M van der Kraan; W B van den Berg
Journal:  Agents Actions       Date:  1990-03

2.  Distribution of 2-naphthol sulphotransferase and its endogenous substrate adenosine 3'-phosphate 5'-phosphosulphate in human tissues.

Authors:  M Cappiello; M Franchi; L Giuliani; G M Pacifici
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

3.  Physiologically based modeling of the pharmacokinetics of acetaminophen and its major metabolites in humans using a Bayesian population approach.

Authors:  Todd J Zurlinden; Brad Reisfeld
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2015-01-31       Impact factor: 2.441

4.  Effect of polysaccharide peptide (PSP) on in vivo sulphation and glucuronidation of paracetamol in the rat.

Authors:  J H Yeung; L C Chiu; V E Ooi
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1995 Oct-Dec       Impact factor: 2.441

5.  Effect of taurolithocholate on in vivo sulfation and glucuronidation of acetaminophen in rats.

Authors:  R E Galinsky; B Chałasinska
Journal:  Pharm Res       Date:  1988-01       Impact factor: 4.200

6.  Time-dependent, plasma-sulfate-independent kinetics of salicylamide in dogs.

Authors:  J A Waschek; R M Fielding; T N Tozer; D J Effeney; S M Pond
Journal:  J Pharmacokinet Biopharm       Date:  1988-04

7.  Pharmacokinetic consequences and toxicologic implications of metyrapone-induced alterations of acetaminophen elimination in man.

Authors:  R E Galinsky; E B Nelson; D E Rollins
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

8.  Intestinal metabolism of ethinyloestradiol and paracetamol in vitro: studies using Ussing chambers.

Authors:  S M Rogers; D J Back; M L Orme
Journal:  Br J Clin Pharmacol       Date:  1987-06       Impact factor: 4.335

Review 9.  Review: Mechanisms of How the Intestinal Microbiota Alters the Effects of Drugs and Bile Acids.

Authors:  Curtis D Klaassen; Julia Yue Cui
Journal:  Drug Metab Dispos       Date:  2015-08-10       Impact factor: 3.922

10.  A novel approach for estimating ingested dose associated with paracetamol overdose.

Authors:  Todd J Zurlinden; Kennon Heard; Brad Reisfeld
Journal:  Br J Clin Pharmacol       Date:  2015-12-09       Impact factor: 4.335

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.